Employees: 03 (2023.0)Legal category: 5585Size: PMECreation date: 2006-04-01 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CRECY-LA-CHAPELLE (77580), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU BEFFROI : revenue, balance sheet and financial ratios
PHARMACIE DU BEFFROI is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CRECY-LA-CHAPELLE (77580),
this company of category PME
shows in 2024 a net income positive of 119 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU BEFFROI (SIREN 489599472)
Indicator
2024
2023
2019
2018
2016
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
118 877 €
196 388 €
151 204 €
128 678 €
169 846 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DU BEFFROI generates positive net income of 119 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 170 k€ -> 119 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
118 877 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 109%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
109.255%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.315%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU BEFFROI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2023
2024
Debt ratio
90.55
330.64
227.357
129.002
109.255
Financial autonomy
47.028
20.671
26.51
37.897
42.315
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
109.252024
2019
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-9 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU BEFFROI (109.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.31%2024
2019
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+11 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU BEFFROI (42.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 305.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
305.32
Liquidity indicators evolution PHARMACIE DU BEFFROI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2023
2024
Liquidity ratio
147.396
184.744
184.873
287.61
305.32
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
305.322024
2019
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent+19 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DU BEFFROI (305.32) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DU BEFFROI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU BEFFROI is estimated at
1 659 610 €
(range 1 155 726€ - 2 482 872€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1155k€1659k€2482k€
1 659 610 €Range: 1 155 726€ - 2 482 872€
NAF 5 année 2024
Valuation method used
Net Income Multiple
118 877 €
×
14.0x
=1 659 611 €
Range: 1 155 727€ - 2 482 873€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU BEFFROI with other companies in the same sector:
Frequently asked questions about PHARMACIE DU BEFFROI
What is the revenue of PHARMACIE DU BEFFROI ?
The revenue of PHARMACIE DU BEFFROI is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU BEFFROI profitable?
Yes, PHARMACIE DU BEFFROI generated a net profit of 119 k€ in 2024.
Where is the headquarters of PHARMACIE DU BEFFROI ?
The headquarters of PHARMACIE DU BEFFROI is located in CRECY-LA-CHAPELLE (77580), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE DU BEFFROI ?
The tax return of PHARMACIE DU BEFFROI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU BEFFROI operate?
PHARMACIE DU BEFFROI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart